Skip to content

Geron GERN Interest Expense

Interest Expense at other companies

Incyte logo
IncyteINCY
$569K-13.8%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M+200%
Celcuity logo
CelcuityCELC
$6.09M+91.2%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.21M
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$5.59M+62.6%

Segments

By segment

See full
Reportable Segment-$3.7M-19.4%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's interest expense?
Geron (GERN) reported interest expense of $7.15M in Q1 2026.
How has Geron's interest expense changed year-over-year?
Geron's interest expense decreased by 12.8% year-over-year, from $8.2M to $7.15M.
What is the long-term trend for Geron's interest expense?
Over 4 years (2021 to 2025), Geron's interest expense has grown at a 71.9% compound annual growth rate (CAGR), from $3.74M to $32.66M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.